BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8942749)

  • 1. Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori.
    Nagashima R; Takeda H; Maeda K; Ohno S; Takahashi T
    Gastroenterology; 1996 Dec; 111(6):1674-8. PubMed ID: 8942749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue.
    de Mascarel A; Ruskone-Fourmestraux A; Lavergne-Slove A; Megraud F; Dubus P; Merlio JP
    Virchows Arch; 2005 Mar; 446(3):219-24. PubMed ID: 15742170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regression of MALT lymphoma of the rectum after Helicobacter pylori eradication therapy in a patient negative for Helicobacter pylori].
    Nomura E; Uchimi K; Abue M; Kon H; Noguchi T; Suzuki S; Suzuki M; Onodera H; Tateno H; Ota Y
    Nihon Shokakibyo Gakkai Zasshi; 2010 Sep; 107(9):1466-73. PubMed ID: 20827043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
    Ruskoné-Fourmestraux A; Lavergne A; Aegerter PH; Megraud F; Palazzo L; de Mascarel A; Molina T; Rambaud JL
    Gut; 2001 Mar; 48(3):297-303. PubMed ID: 11171816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in pattern of immunoglobulin heavy chain gene rearrangement and MIB-1 staining before and after eradication of Helicobacter pylori in gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
    Kanda M; Suzumiya J; Ohshima K; Okada M; Tamura K; Kikuchi M
    Leuk Lymphoma; 2001 Aug; 42(4):639-47. PubMed ID: 11697492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response].
    Montalbán C; Manzanal A; Boixeda D; Redondo C; Alvarez I; Frutos B; Calleja JL; Sánchez-Godoy P; Bellas C
    Med Clin (Barc); 1998 Jan; 110(2):41-4. PubMed ID: 9534129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
    Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
    J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S; Sano T; Endo H; Kawamata H; Urakami Y
    J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy.
    Arima N; Tsudo M
    Br J Haematol; 2003 Mar; 120(5):790-2. PubMed ID: 12614211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.
    Hiyama T; Haruma K; Kitadai Y; Ito M; Masuda H; Miyamoto M; Tanaka S; Yoshihara M; Sumii K; Shimamoto F; Chayama K
    Int J Oncol; 2001 Jun; 18(6):1207-12. PubMed ID: 11351252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of gastric MALT lymphoma regressed endoscopically and pathologically after eradication of Helicobacter pylori].
    Seko A; Amano K; Shimizu H; Takagi S; Goto A; Kondo H; Sugie S; Yoshimi N; Moriwaki H; Muto Y
    Nihon Shokakibyo Gakkai Zasshi; 1997 Jan; 94(1):21-6. PubMed ID: 9028139
    [No Abstract]   [Full Text] [Related]  

  • 15. Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori.
    Raderer M; Pfeffel F; Pohl G; Mannhalter C; Valencak J; Chott A
    Gut; 2000 Jan; 46(1):133-5. PubMed ID: 10601069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regression of primary low-grade gastric mucosa-associated lymphoma by eradication of Helicobacter pylori infection: case report].
    Sciumè C; Geraci G; Pisello F; Li Volsi F; Facella T; Modica G
    Ann Ital Chir; 2004; 75(1):63-8; discussion 69. PubMed ID: 15283390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of MALT lymphomas coexisting in the duodenal bulb and the stomach by eradication of Helicobacter pylori.
    Hori K; Nishigami T; Chiba T; Matsushima Y; Kojima T
    J Gastroenterol; 2002; 37(4):288-92. PubMed ID: 11993513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
    Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
    Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
    Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
    World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.